메뉴 건너뛰기




Volumn 24, Issue 17, 2014, Pages 4132-4140

Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffold

Author keywords

Kinase inhibitors; Leucine rich repeat kinase 2; LRRK2; Triazolopyridazine

Indexed keywords

G 2019S; LEUCINE RICH REPEAT KINASE 2; PROTEIN SERINE THREONINE KINASE INHIBITOR; PYRIDAZINE DERIVATIVE; TRIAZOLOPYRIDAZINE DERIVATIVE; UNCLASSIFIED DRUG; [1,2,4]TRIAZOLO[4,3 BETA]PYRIDAZINE; FUSED HETEROCYCLIC RINGS; LRRK2 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; TRIAZOLE DERIVATIVE;

EID: 84906934296     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2014.07.052     Document Type: Article
Times cited : (26)

References (46)
  • 34
    • 72449185642 scopus 로고    scopus 로고
    • For a review of blood brain barrier penetration see: A. Reichel Chem. Biodiversity 6 2009 2030
    • (2009) Chem. Biodiversity , vol.6 , pp. 2030
    • Reichel, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.